Registered entities
Kolltan Pharmaceuticals, Inc.
Reg. No. 261476129United States
Innovation
14 patent families (3 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 2,422 times.
| Year | Filings |
|---|---|
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 10 |
| 2016 | 5 |
| 2017 | 7 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2023 | 1 |
Investor mix
11 investors on record; lead investors include KLP Enterprises, Purdue Pharma, HBM Partners; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 55% |
| Private equity | 2 | 18% |
| Bank & private debt | 1 | 9% |
| Other / undisclosed | 2 | 18% |